Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

Baden, Lindsey R; Walsh, Stephen R; Seaman, Michael S; Cohen, Yehuda Z; Johnson, Jennifer A; Licona, J Humberto; Filter, Rachel D; Kleinjan, Jane A; Gothing, Jon A; Jennings, Julia; Peter, Lauren; Nkolola, Joseph; Abbink, Peter; Borducchi, Erica N; Kirilova, Marinela; Stephenson, Kathryn E; Pegu, Poonam; Eller, Michael A; Trinh, Hung V; Rao, Mangala; Ake, Julie A; Sarnecki, Michal; Nijs, Steven; Callewaert, Katleen; Schuitemaker, Hanneke; Hendriks, Jenny; Pau, Maria G; Tomaka, Frank; Korber, Bette T; Alter, Galit; Dolin, Raphael; Earl, Patricia L; Moss, Bernard; Michael, Nelson L; Robb, Merlin L; Barouch, Dan H.

J Infect Dis ; 218(4): 633-644, 2018 07 13.

Artigo em Inglês | MEDLINE | ID: mdl-29669026

2.

Remdesivir - An Important First Step.

Dolin, Raphael; Hirsch, Martin S.

N Engl J Med ; 383(19): 1886-1887, 2020 11 05.

Artigo em Inglês | MEDLINE | ID: mdl-32459913

3.

Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.

Baden, Lindsey R; Karita, Etienne; Mutua, Gaudensia; Bekker, Linda-Gail; Gray, Glenda; Page-Shipp, Liesl; Walsh, Stephen R; Nyombayire, Julien; Anzala, Omu; Roux, Surita; Laher, Fatima; Innes, Craig; Seaman, Michael S; Cohen, Yehuda Z; Peter, Lauren; Frahm, Nicole; McElrath, M Juliana; Hayes, Peter; Swann, Edith; Grunenberg, Nicole; Grazia-Pau, Maria; Weijtens, Mo; Sadoff, Jerry; Dally, Len; Lombardo, Angela; Gilmour, Jill; Cox, Josephine; Dolin, Raphael; Fast, Patricia; Barouch, Dan H; Laufer, Dagna S.

Ann Intern Med ; 164(5): 313-22, 2016 Mar 01.

Artigo em Inglês | MEDLINE | ID: mdl-26833336

4.

Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.

Baden, Lindsey R; Liu, Jinyan; Li, Hualin; Johnson, Jennifer A; Walsh, Stephen R; Kleinjan, Jane A; Engelson, Brian A; Peter, Lauren; Abbink, Peter; Milner, Danny A; Golden, Kevin L; Viani, Kyle L; Stachler, Matthew D; Chen, Benjamin J; Pau, Maria G; Weijtens, Mo; Carey, Brittany R; Miller, Caroline A; Swann, Edith M; Wolff, Mark; Loblein, Hayley; Seaman, Michael S; Dolin, Raphael; Barouch, Dan H.

J Infect Dis ; 211(4): 518-28, 2015 Feb 15.

Artigo em Inglês | MEDLINE | ID: mdl-25165165

5.

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).

Baden, Lindsey R; Walsh, Stephen R; Seaman, Michael S; Johnson, Jennifer A; Tucker, Robert P; Kleinjan, Jane A; Gothing, Jon A; Engelson, Brian A; Carey, Brittany R; Oza, Avinash; Bajimaya, Shringkhala; Peter, Lauren; Bleckwehl, Chelsea; Abbink, Peter; Pau, Maria G; Weijtens, Mo; Kunchai, Meghan; Swann, Edith M; Wolff, Mark; Dolin, Raphael; Barouch, Dan H.

J Infect Dis ; 210(7): 1052-61, 2014 Oct 01.

Artigo em Inglês | MEDLINE | ID: mdl-24719474

6.

Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.

Walsh, Stephen R; Wilck, Marissa B; Dominguez, David J; Zablowsky, Elise; Bajimaya, Shringkhala; Gagne, Lisa S; Verrill, Kelly A; Kleinjan, Jane A; Patel, Alka; Zhang, Ying; Hill, Heather; Acharyya, Aruna; Fisher, David C; Antin, Joseph H; Seaman, Michael S; Dolin, Raphael; Baden, Lindsey R.

J Infect Dis ; 207(12): 1888-97, 2013 Jun 15.

Artigo em Inglês | MEDLINE | ID: mdl-23482644

7.

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

Barouch, Dan H; Liu, Jinyan; Peter, Lauren; Abbink, Peter; Iampietro, M Justin; Cheung, Ann; Alter, Galit; Chung, Amy; Dugast, Anne-Sophie; Frahm, Nicole; McElrath, M Juliana; Wenschuh, Holger; Reimer, Ulf; Seaman, Michael S; Pau, Maria G; Weijtens, Mo; Goudsmit, Jaap; Walsh, Stephen R; Dolin, Raphael; Baden, Lindsey R.

J Infect Dis ; 207(2): 248-56, 2013 Jan 15.

Artigo em Inglês | MEDLINE | ID: mdl-23125443

8.

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).

Baden, Lindsey R; Walsh, Stephen R; Seaman, Michael S; Tucker, Robert P; Krause, Kathleen H; Patel, Alka; Johnson, Jennifer A; Kleinjan, Jane; Yanosick, Katherine E; Perry, James; Zablowsky, Elise; Abbink, Peter; Peter, Lauren; Iampietro, M Justin; Cheung, Ann; Pau, Maria G; Weijtens, Mo; Goudsmit, Jaap; Swann, Edith; Wolff, Mark; Loblein, Hayley; Dolin, Raphael; Barouch, Dan H.

J Infect Dis ; 207(2): 240-7, 2013 Jan 15.

Artigo em Inglês | MEDLINE | ID: mdl-23125444

9.

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.

Baden, Lindsey R; Blattner, William A; Morgan, Cecilia; Huang, Yunda; Defawe, Olivier D; Sobieszczyk, Magdalena E; Kochar, Nidhi; Tomaras, Georgia D; McElrath, M Juliana; Russell, Nina; Brandariz, Kara; Cardinali, Massimo; Graham, Barney S; Barouch, Dan H; Dolin, Raphael.

J Infect Dis ; 204(10): 1541-9, 2011 Nov 15.

Artigo em Inglês | MEDLINE | ID: mdl-21940420

10.

Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.

Seaman, Michael S; Wilck, Marissa B; Baden, Lindsey R; Walsh, Stephen R; Grandpre, Lauren E; Devoy, Colleen; Giri, Ayush; Noble, Lizanne C; Kleinjan, Jane A; Stevenson, Kristen E; Kim, Haesook T; Dolin, Raphael.

J Infect Dis ; 201(9): 1353-60, 2010 May 01.

Artigo em Inglês | MEDLINE | ID: mdl-20350190

11.

Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.

Wilck, Marissa B; Seaman, Michael S; Baden, Lindsey R; Walsh, Stephen R; Grandpre, Lauren E; Devoy, Colleen; Giri, Ayush; Kleinjan, Jane A; Noble, Lizanne C; Stevenson, Kristen E; Kim, Haesook T; Dolin, Raphael.

J Infect Dis ; 201(9): 1361-70, 2010 May 01.

Artigo em Inglês | MEDLINE | ID: mdl-20350191

12.

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.

Oganezova, Karina; Fontana-Martinez, Elvin J; Gothing, Jon A; Pandit, Alisha; Kwara, Esther; Yanosick, Katherine; Dragavon, Joan; Goecker, Erin A; Maenza, Janine; Espy, Nicole; Tomaka, Frank; Lavreys, Ludo; Allen, Mary; D'Souza, Patricia; Hural, John; Coombs, Robert W; Dolin, Raphael; Seaman, Michael S; Walsh, Stephen R; Baden, Lindsey R.

Open Forum Infect Dis ; 8(1): ofaa606, 2021 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-33511233

13.

The road to an effective HIV vaccine.

Baden, Lindsey R; Dolin, Raphael.

N Engl J Med ; 366(14): 1343-4, 2012 Apr 05.

Artigo em Inglês | MEDLINE | ID: mdl-22475599

14.

The quadrivalent approach to influenza vaccination.

Dolin, Raphael.

J Infect Dis ; 208(4): 539-40, 2013 Aug 15.

Artigo em Inglês | MEDLINE | ID: mdl-23847061

15.

HIV vaccine trial results--an opening for further research.

Dolin, Raphael.

N Engl J Med ; 361(23): 2279-80, 2009 Dec 03.

Artigo em Inglês | MEDLINE | ID: mdl-19843556

16.

Editorial commentary: Perspectives on the role of immunization against influenza in HIV-infected patients.

Dolin, Raphael.

Clin Infect Dis ; 52(1): 147-9, 2011 Jan 01.

Artigo em Inglês | MEDLINE | ID: mdl-21148533

17.

Resistance to neuraminidase inhibitors.

Dolin, Raphael.

Clin Infect Dis ; 52(4): 438-9, 2011 Feb 15.

Artigo em Inglês | MEDLINE | ID: mdl-21248366

18.

A new class of anti-HIV therapy and new challenges.

Dolin, Raphael.

N Engl J Med ; 359(14): 1509-11, 2008 Oct 02.

Artigo em Inglês | MEDLINE | ID: mdl-18832250

19.

Noroviruses--challenges to control.

Dolin, Raphael.

N Engl J Med ; 357(11): 1072-3, 2007 Sep 13.

Artigo em Inglês | MEDLINE | ID: mdl-17855667

20.

Influenza--interpandemic as well as pandemic disease.

Dolin, Raphael.

N Engl J Med ; 353(24): 2535-7, 2005 Dec 15.

Artigo em Inglês | MEDLINE | ID: mdl-16354889

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

Remdesivir - An Important First Step.

Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.

Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).

Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).

Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.

Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.

Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.

The road to an effective HIV vaccine.

The quadrivalent approach to influenza vaccination.

HIV vaccine trial results--an opening for further research.

Editorial commentary: Perspectives on the role of immunization against influenza in HIV-infected patients.

Resistance to neuraminidase inhibitors.

A new class of anti-HIV therapy and new challenges.

Noroviruses--challenges to control.

Influenza--interpandemic as well as pandemic disease.